Bernstein Karen 4
4 · Ovid Therapeutics Inc. · Filed Jun 10, 2019
Insider Transaction Report
Form 4
Bernstein Karen
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-07+5,813→ 5,813 totalExercise: $1.60Exp: 2029-06-06→ Common Stock (5,813 underlying)
Footnotes (1)
- [F1]The option will vest in full on June 7, 2020, subject to the Reporting Person's continuous service through such vesting date.